Home
Philips - Click here to navigate to the homepage

Search terms

News center | Global
Back to results

Stellarex 0.014 OTW Drug-Coated Balloon in use

Stellarex 0.014” OTW Drug-Coated Balloon in use
Asset published on November 12, 2018
Select your preferred file
Download Copy download link

Description

"Two medical specialists inserting the Stellarex 0.014"" OTW Drug-Coated balloon into an artery."

Topics

Precision medicine Cardiology

Related articles

Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
Four-year results from patient-level meta-analysis confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon
New data reconfirms long-term safety profile of the Philips Stellarex low-dose Drug-Coated Balloon
Four-year data from ILLUMENATE Pivotal trial reaffirms safety profile of Philips Stellarex low-dose Drug-Coated Balloon
Philips introduces new 200mm and 150mm Stellarex 0.035” low-dose drug-coated balloons to broaden treatment options for peripheral artery disease patients
Third-party evaluation confirms safety profile of Philips Stellarex .035″ low-dose drug-coated balloon
Philips announces first U.S. patient enrolled in ILLUMENATE study of Stellarex 0.014 Drug-Coated Balloon for below-the-knee peripheral artery disease

Related assets